1
|
Burtscher B, Manco Urbina PA, Diacci C, Borghi S, Pinti M, Cossarizza A, Salvarani C, Berggren M, Biscarini F, Simon DT, Bortolotti CA. Sensing Inflammation Biomarkers with Electrolyte-Gated Organic Electronic Transistors. Adv Healthc Mater 2021; 10:e2100955. [PMID: 34423579 DOI: 10.1002/adhm.202100955] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2021] [Revised: 07/16/2021] [Indexed: 01/08/2023]
Abstract
An overview of cytokine biosensing is provided, with a focus on the opportunities provided by organic electronic platforms for monitoring these inflammation biomarkers which manifest at ultralow concentration levels in physiopathological conditions. Specifically, two of the field's state-of-the-art technologies-organic electrochemical transistors (OECTs) and electrolyte gated organic field effect transistors (EGOFETs)-and their use in sensing cytokines and other proteins associated with inflammation are a particular focus. The overview will include an introduction to current clinical and "gold standard" quantification techniques and their limitations in terms of cost, time, and required infrastructure. A critical review of recent progress with OECT- and EGOFET-based protein biosensors is presented, alongside a discussion onthe future of these technologies in the years and decades ahead. This is especially timely as the world grapples with limited healthcare diagnostics during the Coronavirus disease (COVID-19)pandemic where one of the worst-case scenarios for patients is the "cytokine storm." Clearly, low-cost point-of-care technologies provided by OECTs and EGOFETs can ease the global burden on healthcare systems and support professionals by providing unprecedented wealth of data that can help to monitor disease progression in real time.
Collapse
Affiliation(s)
- Bernhard Burtscher
- Laboratory of Organic Electronics Department of Science and Technology Linköping University Norrköping 60174 Sweden
| | | | - Chiara Diacci
- Laboratory of Organic Electronics Department of Science and Technology Linköping University Norrköping 60174 Sweden
| | - Simone Borghi
- Department of Life Sciences University of Modena and Reggio Emilia Via Campi 103 Modena 41125 Italy
| | - Marcello Pinti
- Department of Life Sciences University of Modena and Reggio Emilia Via Campi 103 Modena 41125 Italy
| | - Andrea Cossarizza
- Department of Medical and Surgical Sciences for Children and Adults University of Modena and Reggio Emilia Via Campi 287 Modena 41125 Italy
| | - Carlo Salvarani
- Rheumatology Unit University of Modena and Reggio Emilia Medical School Azienda Ospedaliero‐Universitaria Policlinico di Modena Modena 41124 Italy
| | - Magnus Berggren
- Laboratory of Organic Electronics Department of Science and Technology Linköping University Norrköping 60174 Sweden
| | - Fabio Biscarini
- Department of Life Sciences University of Modena and Reggio Emilia Via Campi 103 Modena 41125 Italy
- Center for Translation Neurophysiology Istituto Italiano di Tecnologia Via Fossato di Mortara 17–19 Ferrara 44100 Italy
| | - Daniel T. Simon
- Laboratory of Organic Electronics Department of Science and Technology Linköping University Norrköping 60174 Sweden
| | - Carlo A. Bortolotti
- Department of Life Sciences University of Modena and Reggio Emilia Via Campi 103 Modena 41125 Italy
| |
Collapse
|
3
|
Blood pressure regulation by CD4 + lymphocytes expressing choline acetyltransferase. Nat Biotechnol 2016; 34:1066-1071. [PMID: 27617738 PMCID: PMC5513182 DOI: 10.1038/nbt.3663] [Citation(s) in RCA: 64] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2016] [Accepted: 08/04/2016] [Indexed: 12/12/2022]
Abstract
Blood pressure regulation is known to be maintained by a neuro-endocrine circuit, but whether immune cells contribute to blood pressure homeostasis has not been determined. We previously showed that CD4+ T lymphocytes that express choline acetyltransferase (ChAT), which catalyzes the synthesis of the vasorelaxant acetylcholine, relay neural signals. Here we show that these CD4+CD44hiCD62Llo T helper cells by gene expression are a distinct T-cell population defined by ChAT (CD4 TChAT). Mice lacking ChAT expression in CD4+ cells have elevated arterial blood pressure, compared to littermate controls. Jurkat T cells overexpressing ChAT (JTChAT) decreased blood pressure when infused into mice. Co-incubation of JTChAT and endothelial cells increased endothelial cell levels of phosphorylated endothelial nitric oxide synthase, and of nitrates and nitrites in conditioned media, indicating increased release of the potent vasorelaxant nitric oxide. The isolation and characterization of CD4 TChAT cells will enable analysis of the role of these cells in hypotension and hypertension, and may suggest novel therapeutic strategies by targeting cell-mediated vasorelaxation.
Collapse
|
4
|
Lerman I, Hauger R, Sorkin L, Proudfoot J, Davis B, Huang A, Lam K, Simon B, Baker DG. Noninvasive Transcutaneous Vagus Nerve Stimulation Decreases Whole Blood Culture-Derived Cytokines and Chemokines: A Randomized, Blinded, Healthy Control Pilot Trial. Neuromodulation 2016; 19:283-90. [PMID: 26990318 DOI: 10.1111/ner.12398] [Citation(s) in RCA: 110] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2015] [Revised: 11/20/2015] [Accepted: 12/17/2015] [Indexed: 12/12/2022]
Abstract
OBJECTIVES The purpose of this study was to test the transcutaneous noninvasive vagus nerve stimulator (nVNS) (gammaCore©) device to determine if it modulates the peripheral immune system, as has been previously published for implanted vagus nerve stimulators. MATERIALS AND METHODS A total of 20 healthy males and females were randomized to receive either nVNS or sham stimulation (SST). All subjects underwent an initial blood draw at 8:00 am, followed by stimulation with nVNS or SST at 8:30 am. Stimulation was repeated at 12:00 pm and 6:00 pm. Additional blood samples were withdrawn 90 min and 24 hour after the first stimulation session. After samples were cultured using the Myriad RBM TruCulture (Austin, TX) system (WBCx), levels of cytokines and chemokines were measured by the Luminex assay and statistical analyses within and between groups were performed using the Wilcoxon Signed Ranks Test and Mann-Whitney U with the statistical program R. RESULTS A significant percent decrease in the levels of the cytokine interleukin [IL]-1β, tumor necrosis factor [TNF] levels, and chemokine, interleukin [IL]-8 IL-8, macrophage inflammatory protein [MIP]-1α, and monocyte chemoattractant protein [MCP]-1 levels was observed in the nVNS group non-lipopolysaccharide (LPS)-stimulated whole blood culture (n-WBCx) at the 24-hour time point (p < 0.05). In SST group, there was a significant percent increase in IL-8 at 90 min post-stimulation (p < 0.05). At 90 min, the nVNS group had a greater percent decrease in IL-8 concentration (p < 0.05) compared to SST group. The nVNS group had a greater percent decrease in cytokines (TNF, IL-1β) and chemokines (MCP-1 and IL-8) at 24 hour (p < 0.05) in comparison to SST. LPS-stimulated whole blood cultures (L-WBCx) did not show a significant decrease in cytokine levels in either the nVNS or SST group across any time points. The nVNS group showed a significant percent increase in LPS-stimulated IL-10 levels at the 24-hour time point in comparison to SST. CONCLUSIONS nVNS downregulates inflammatory cytokine release suggesting that nVNS may be an effective anti-inflammatory treatment.
Collapse
Affiliation(s)
- Imanuel Lerman
- Department of Psychiatry, Center of Excellence for Stress and Mental Health, San Diego, CA, USA.,Department of Psychiatry, VA San Diego Healthcare System, San Diego, CA, USA.,Department of Anesthesiology, University of California, San Diego, San Diego, CA, USA.,Department of Psychiatry, University of California, San Diego, San Diego, CA, USA
| | - Richard Hauger
- Department of Psychiatry, Center of Excellence for Stress and Mental Health, San Diego, CA, USA.,Department of Psychiatry, VA San Diego Healthcare System, San Diego, CA, USA.,Department of Psychiatry, University of California, San Diego, San Diego, CA, USA
| | - Linda Sorkin
- Department of Anesthesiology, University of California, San Diego, San Diego, CA, USA
| | - James Proudfoot
- Department of Anesthesiology, Clinical and Translational Research Institute, University of California, San Diego, San Diego, CA, USA
| | - Bryan Davis
- Department of Anesthesiology, University of California, San Diego, San Diego, CA, USA
| | - Andy Huang
- Department of Anesthesiology, University of California, San Diego, San Diego, CA, USA
| | - Katie Lam
- Department of Anesthesiology, University of California, San Diego, San Diego, CA, USA
| | - Bruce Simon
- Electrocore Research Unit, Basking Ridge, NJ, USA
| | - Dewleen G Baker
- Department of Psychiatry, Center of Excellence for Stress and Mental Health, San Diego, CA, USA.,Department of Psychiatry, VA San Diego Healthcare System, San Diego, CA, USA.,Department of Psychiatry, University of California, San Diego, San Diego, CA, USA
| |
Collapse
|